c-LEcta GmbH
Andreas Vogel is an accomplished professional in the field of enzyme development, currently serving as Vice President of R&D at c-LEcta GmbH since June 2021, with a prior role as Head of R&D Enzyme Development from February 2006 to July 2021. At c-LEcta, Andreas specializes in the development of enzymes for industrial applications. Earlier career experiences include postdoctoral positions at the Max-Planck-Institute for Coal Research and EMBL outstation Hamburg, with a focus on structural biology, enzymology, and molecular biology. Andreas obtained a Ph.D. in Biochemistry/Chemistry from the University of Münster between 1997 and 2000.
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.